what is the survival rate from uterus cancer?

Question

we are going thru some tough times with a hysterectamy operation things are fine now but we are waiting for when my friend goes thru therapy radiation and chemo is this good ? she' 52 yrs old we have a 15 yr old son thats ok everything was remove even overies

Answer 1

A site I found about it says this:

"The survival rate for uterine cancer generally depends upon the individual health of the patient. However, average rates can be determined. The prognosis for endometrial cancer is typically good. If caught early, the five year survival rate is between 75% and 95%. The prognosis for uterine sarcomas is less promising. If caught early, there is a five-year survival rate of between 20% and 50%. In its most advanced stages, the five-year survival rate is only 10%."

The site is http://www.epigee.org/health/uterine_treatment.html

The wikipedia site says this:

"The American Cancer Society estimates that 41,200 women will be diagnosed with uterine cancer in 2006, and of those 7,350 will die. About 70% of all women diagnosed are between the ages of 45-74. A woman’s chance of developing this cancer through out her life time is about 1 in 38. 500,000 women have been diagnosed and survived this cancer. This cancer is 40% more prominently found in white women, however an African American women who is diagnosed with uterine cancer is twice as likely to die. Doctors say that on average the five-year survival rate is at 84%, and this percentage increases if the cancer is detected in early stages."

http://en.wikipedia.org/wiki/Uterine_cancer

~Kyle

Answer 2

The survival rate for uterine cancer generally depends upon the individual health of the patient. However, average rates can be determined. The prognosis for endometrial cancer is typically good. If caught early, the five year survival rate is between 75% and 95%. The prognosis for uterine sarcomas is less promising. If caught early, there is a five-year survival rate of between 20% and 50%. In its most advanced stages, the five-year survival rate is only 10%.

Answer 3

The critical question is whether your mother's uterine cancer has metastasized or a new primary cancer has formed. The prognosis for each diseases is different, but neither is very favorable. Metastasized uterine cancer cannot be eradicated, so the prognosis in that case is poor. Primary lung cancer is treatable, but survival rates are not good.. You can read more at the attached websites:

For the best answers, search on this site https://smarturl.im/aDBMT

Answer 4

Uterine Papillary Serous Carcinoma Survivors

Answer 5

This secret set the medical world on fire!

A 102 year old doctor exposes the myths regarding the real cause of diseases...

And shows you a simple thing you can do right now in your home...that will bulletproof you against life-debilitating illnesses: including heart attack, Cancer, Diabetes, Alzheimer's and MORE...

Click Here Before The Video Gets Taken Down - http://reversediseasetoday.info/Big-Secrets-3631x.html

If Big Pharma gets wind of this, they'll send their lawyers to try to take down the site.

This simple thing doesn't cost you a single cent, and it will destroy Big Pharma's business of selling drugs.

Click Here Before Big Pharma Ban This Video - http://reversediseasetoday.info/Big-Secrets-3631x.html

God Bless,
Ken

P/s: More than 20,392 people have already watched the video...and I'm receiving tens of emails everyday telling me how they are reversing their chronic conditions...in less than 72 hours!

Answer 6

The survival rate for Uterine Cancer is very good if caught early enough. The combo of Radiation and Chemo doesnt hurt either. Please see the website I posted below for you, it is a very useful site. Also, for cancer survivors you should try your local area for support groups. Even if you think that yourfriend is fine she can probaly help those women out there who arent.

Answer 7

Big Pharma Companies Hate This...

Hello, my name is Ken Drew...

In this short and controversial health exposé, I’m going reveal the one amazing little secret, long suppressed by Big Pharma, that will bulletproof your body against the scary illnesses like Cancer, Heart disease, Diabetes, Alzheimer's, Arthritis and more....and its something that you can do right now in your home.

Without ever popping a single pill, getting any dreaded needle, prescriptions of any kind. Even sidestepping alternative therapies that never seem to work. Ineffective supplements that waste time and frustrate you to no end. Not to mention tear a hole in your wallet...
...Or even put you in an early grave.

Think of how you felt today - http://reversediseasetoday.info/simple/young-again-926.html

Answer 8

Survival rates

The 5-year survival rate for endometrial cancer following appropriate treatment is:

* 75% to 95% for stage 1
* 50% for stage 2
* 30% for stage 3
* less than 5% for stage 4

Endometrial carcinoma is surgically staged using the FIGO cancer staging system.

* Stage IA: tumor is limited to the endometrium
* Stage IB: invasion of less than half the myometrium
* Stage IC: invasion of more than half the myometrium
* Stage IIA: endocervical glandular involvement only
* Stage IIB: cervical stromal invasion
* Stage IIIA: tumor invades serosa or adnexa, or malignant peritoneal cytology
* Stage IIIB: vaginal metastasis
* Stage IIIC: metastasis to pelvic or para-aortic lymph nodes
* Stage IVA: invasion of the bladder or bowel
* Stage IVB: distant metastasis, including intraabdominal or inguinal lymph nodes

Best wishes to all involved

Answer 9

Forget anything you have ever been told about Diabetes. And get this - it has nothing to do with insulin, exercise, diet or anything else you've heard in the past. It's all based on latest breakthrough research that Big Pharma is going Stir Crazy to hide from you. Visit here : https://tinyurl.im/aH1V3 to find out what all the fuss is about.

Answer 10

It depends on the stage of the cancer

Here's an exceprt from the link below

As stated earlier, because of the typical early clinical presentation, most cases of endometrial cancer are endometrioid adenocarcinoma that is well-differentiated and stage I disease. Overall 5-year survival rates for all grades and histological subtypes are 87%, 72%, 51%, and 9% for surgical stage I, II, III, and IV disease, respectively. Overall 5-year survival rates for all grades and histological subtypes is 69%, 48%, 31%, and 13% for clinical stage I, II, III, and IV disease, respectively. The nuclear grade is an important determinant of prognosis. For surgical stage I disease, 5-year survival rates for grade 1, 2, and 3 endometrial carcinoma is 92%, 87%, and 74%, respectively.

In terms of histologic subtype, clear cell and papillary serous carcinomas have the lowest overall 5-year survival rates. When considering all stages together, the 5-year survival rates for clear cell and papillary serous carcinomas are 51% and 46%, respectively. Endometrioid adenocarcinoma has an overall 5-year survival rate of approximately 76%. Adenosquamous carcinoma has an overall 5-year survival rate of approximately 68%.

Increasing nuclear grade is associated with deeper myometrial invasion. Deeper myometrial invasion is, in turn, associated with pelvic and para-aortic lymph node metastases. These are all adverse prognostic factors. Recurrence rates up to 46% are observed with deep myometrial invasion (greater than one-half) as compared to 8-13% with superficial or no invasion.

Most recurrences of endometrial cancer are diagnosed within 2 years. Recurrences in patients treated with surgery alone tend to be more localized to the pelvis, particularly at the vaginal cuff. These recurrences are usually salvageable with radiation therapy, surgical excision, occasionally pelvic exenteration, or a combination of surgical excision and radiation. The prognosis for these patients is better if the original diagnosis was more than 2 years before the recurrence.

Endometrial cancer treated with surgery and radiation that does recur is less often localized and, as such, is less amenable to localized therapy such as surgical excision and radiation. The most common extrapelvic sites for recurrences include the lungs, abdomen, para-aortic lymph nodes, brain, bones, and liver. Distant recurrences also present in the anterior scalene, supraclavicular, and inguinal lymph nodes. If the tumor is hormone receptor–rich, it may be amenable to progestin or antiestrogen therapy. Otherwise, the same chemotherapy that is used for advanced endometrial cancer has been studied for recurrent disease, with the same results.

Recurrence is the rule for uterine sarcomas. Stage I uterine sarcomas recur in up to 50% of cases. The overall 5-year survival rate for LMS is 15-25%. Stage I LMS has a 58% and 70% 5-year survival after surgery without and with radiation therapy, respectively. Recurrences are rarely localized and tend to reappear in the lungs most often. Stage I LGESS and HGESS have 5-year survival rates of 80% and 50%, respectively.

As expected, advanced disease has a much worse prognosis, with a 5-year survival rate of 0-33% for stages II-IV. Early-stage MMT has a 5-year survival rate of approximately 50%, while stages II-IV have a 5-year survival rate of 5-15%.